Dental Implant Success Rates: Why a Single Percentage Distorts Clinical Reality

What matters more: Survival or Success?

A common patient question is how to weigh survival versus success. The answer is not as simple as one might hope—but research now provides clear indications.

The conceptual separation between implant survival and implant success was first established in the 1980s by Albrektsson et al., who first formulated objective success criteria: absence of mobility, no persistent peri-implant radiolucency, less than 0.2 mm annual vertical bone loss after the first functional year, and absence of persistent pain, infection, or neuropathy. Since then, the literature has produced numerous modified success criteria—Buser et al. defined additional aesthetic criteria, Misch added prosthetic stability as a parameter, and EAO consensus conferences have repeatedly attempted to establish standardized endpoints—without any single definition achieving universal acceptance. The consequence is fundamental heterogeneity in outcome reporting, which significantly complicates direct comparisons between studies and systematically limits the literature's ability to synthesize multiple studies. In the 9 sources analyzed here, the authors sometimes use different success definitions or report only survival rates, which limits comparability.

Kupka et al. (2024) provide the first systematic review of multiple studies on the 20-year survival rate of screw-shaped titanium implants with a rough surface. The inclusion criteria were deliberately strict: only screw-shaped implants made of titanium or titanium alloy with a rough surface (acid-etched, sandblasted) were included, thereby excluding obsolete implant designs such as hollow screws, hollow cylinders, and implants with machined surfaces. Three prospective studies involving a total of 237 implants yielded an average survival rate of 92%, with moderate heterogeneity of I² = 54%. After imputing the follow-up losses, the case number increased to 422 implants, and the survival rate dropped significantly to 78% with negligible heterogeneity (I² = 0 %, P = 0.39). Five retrospective studies involving 1440 implants showed a Kaplan-Meier survival rate of 88% with very high heterogeneity (I² = 95 %, P < 0.01). The authors strongly emphasize that the discrepancy between the complete case analysis and the imputed data points to significant potential for bias: patients who are lost to follow-up are more likely to have experienced complications or implant loss, and the single study authors unanimously confirm that the reported data likely overestimate the survival rate.

The Padhye et al. meta-analysis of multiple studies (2023) comparing zirconia and titanium implants illustrates the problem of success definition at a material-specific level. The systematic search up to March 2022 identified only 2 RCTs (published in 4 articles) with a total of 100 zirconia and 99 titanium implants followed for 12–80 months, highlighting the limited long-term data available for newer implant materials. While survival rates for both materials showed no statistically significant difference at 12 months (P = 0.0938), the success rates varied considerably: 57.5–93.3% for zirconia and 57.1–100% for titanium implants. This enormous range of success rates within the same material does not reflect biological variability but rather the heterogeneity of the success definitions used. Studies by Payer et al. and Koller et al. defined success as the absence of peri-implant translucency, no implant-associated pain, no infection or paresthesia, and no implant loss, while other studies used different thresholds for bone loss. Studies that report only survival rates convey a uniformly positive picture; once success criteria are applied, this picture fragments into a differentiated mosaic that depicts the clinical reality much better.

The systematic review by Hamilton et al. (2023) regarding immediate implant placement and loading in the aesthetic zone (Type 1A) emphasizes this finding at the prosthetic level. An electronic search of MEDLINE, Embase, and Cochrane identified 3118 publications, of which 68 articles were included, with an average number of implants per study of 37.2 and a mean follow-up of only 2.8 years. All included studies used highly selective inclusion and exclusion criteria for patients and implant sites. Univariate risk group analysis showed that studies conducted before 2012 reported significantly lower mean survival rates than more recent work (Difference: −1.9 percentage points, 95% CI: −0.3 to −4.0; P = 0.02). Furthermore, the facial gap dimension influenced survival rates (+3.1 PP for width > 2 mm, 95% CI: 0.2–5.3; P = 0.04), as did the presence of an endodontic infection (+2.6 PP, 95% CI: 0.9–5.1; P = 0.004). The authors explicitly state that further research is needed to evaluate aesthetic and functional success because the existing literature primarily focuses on survival rates. This suggests that some of the improvement seen in more recent publications might be due to stricter patient selection and shorter follow-up periods, rather than solely technological advancement.

The 5-year survival rates for implant-supported single crowns are estimated in the systematic review for monolithic zirconia crowns at a 3-year survival rate of 96.1%, based on 394 crowns with a mean observation time of 1.6 years and an estimated annual failure rate of 1.31%. For monolithic porcelain-fused-to-metal (PFM) crowns (452 crowns, mean follow-up 2.6 years), the 3-year survival rate is 97.0% with an annual failure rate of 1.02%. Veneered zirconia crowns (952 crowns, mean follow-up 3.8 years) achieve 96.3% with an annual failure rate of 1.27%. Veneered porcelain-fused-to-metal crowns (93 crowns, mean follow-up 8.1 years) show 97.6%. Veneered dense sintered alumina crowns (128 crowns, mean follow-up 3.7 years) achieve 96.9%. While these numbers appear excellent, the parallel complication analysis reveals a different dimension: The estimated annual failure rate due to ceramic fracture for veneered zirconia crowns is 0.98%, corresponding to a cumulative 3-year failure rate of 2.90%. For monolithic zirconia crowns, the fracture-related annual failure rate is lower at 0.58%, corresponding to a 3-year failure rate of 1.72%. Therefore, survival and freedom from complications are two distinctly different clinical realities that must be reported and evaluated separately.

According to Padhye et al. (2023), titanium remains the reference material with a high survival rate of 97.2% after 5 years and 95.2% after 10 years, coupled with documented biocompatibility, low corrosion, and high fracture strength. However, the authors also report material-specific disadvantages: potential discoloration of the peri-implant soft tissue, risk of hypersensitivity reaction, low resistance to peri-implantitis development, and corrosion processes when exposed to fluoride or metal alloys in saliva. Bacterial biofilms can induce oxidation on the titanium surface in an acidic environment, which in turn can trigger an inflammatory response. These material-specific complication mechanisms are not captured in survival analyses but are relevant for long-term clinical success and underscore the need for an endpoint definition that goes beyond mere implant retention.

For daily clinical practice, the distinction between survival and success means that every communicated percentage requires contextual information. A dentist who tells a patient a 95% survival rate after 10 years is only stating that the implant is unlikely to be lost. It says nothing about peri-implant health, prosthetic maintenance needs, aesthetic stability, or long-term functional outcomes. In fact, significant complication burdens can be hidden beneath a high survival rate: biological complications such as mucositis or periodontitis, technical complications like ceramic chipping, screw loosening, or cement loss, and aesthetic complications like soft tissue recession or implant show-through in thin phenotypes.

The practical implication is a demand for differentiated endpoint reporting in clinical communication. Instead of a single number, the consultation should ideally reflect at least three dimensions: the probability of implant retention (Survival), the probability of complication-free function (Success in the narrower sense), and the expected maintenance effort (cumulative complication rate over the planned treatment horizon). Only this approach ensures an informed patient decision. The formulation proposed by Kupka et al. (2024)—that about 4 out of 5 implants survive for 20 years—is a helpful, evidence-based communication benchmark.

In daily practice, this means that scientific evidence does not provide a one-size-fits-all answer but rather a framework for individualized decision-making. Patient-specific factors such as general health, compliance, individual risk profiles, and treatment preferences must be considered in the decision.

What does this mean for you? Survival rates almost always look better than actual definitions of success.

What does this mean for your next dental visit? The research helps you to better contextualize your dentist's recommendations and ask targeted questions if anything is unclear.

Science has intensively investigated this topic in recent years. For this article, more than 11 scientific studies were evaluated. It is important to understand that not every study has the same level of evidence. Large, well-controlled investigations provide more reliable results than small observational studies. The overall picture from these various studies is what we present to you here.

What do "Biological and Technical Complications" mean for me as a patient?

When it comes to biological and technical complications, the research situation is clearer than many people think. Here you will learn what current studies really show.

A systematic review of survival and complication rates for all-ceramic implant-supported single crowns provides the most comprehensive data basis to date regarding prosthetic complications with implant-supported single crowns. From 49 included studies involving a total of 2,160 crowns across 57 material cohorts using various material combinations, a nuanced picture emerges: While survival rates exceed 96% across materials, technical complication rates show considerable variability. Ceramic chipping in veneered zirconia crowns reached estimated 5-year rates of 9.0% according to previous analyses (Rabel et al.). The annual failure rate due to ceramic fractures for veneered zirconia crowns was 0.98%, whereas it was only 0.58% for monolithic zirconia crowns. The relative failure rate for veneered versus monolithic zirconia constructions was 1.69, which was not statistically significant but indicates a clinically noticeable trend toward higher fracture susceptibility in veneered restorations. For monolithic glass-ceramic crowns, the annual failure rate due to fracture was 0.60%, with a relative rate of 1.04 compared to monolithic zirconia (P = 0.953), meaning they are practically identical.

Particularly insightful is the comparison with nano-composite crowns (Resin Matrix Ceramic, RMC), which showed an estimated annual failure rate of 33.8% and a 3-year survival rate of only 36.3%, based on 75 crowns with a mean observation time of 1.8 years in the same review. The relative failure rate was 25.8 compared to monolithic zirconia (P < 0.0001). This extreme example shows that material choice can have a dramatic impact on the prosthetic complication rate, while the implant survival rate itself remains largely unaffected. However, the patient's clinical reality is primarily determined by prosthetic stability and freedom from complications, not merely by implant retention. A patient with an intact implant but a failing RMC crown experiences a clinical failure that is not captured in the implant survival statistics.

The distribution of restoration types in the review also shows relevant patterns: Of the 969 veneered zirconia crowns, 55.4% were cement-retained and 44.6% were screw-retained. For the 394 monolithic zirconia crowns, the ratio was reversed: 27% cemented and 73% screw-retained. The distribution in the jaw was also asymmetrical: 37% anterior and 63% posterior for the total group, but 83% anterior for densely sintered alumina crowns. The dropout rate averaged a median of 4%, although two studies reported over 25%. Of the included studies, 34 were conducted in university settings, 10 in private practices, and 5 in mixed settings. This distribution must be considered when applying the results to routine care.

On the biological side, Kupka et al. (2024) documented in a 20-year observation that radiological bone loss related to the gums is more common in patients with preloaded sites. Becker observed implant losses in 17 patients with gum disease (periodontitis) in the included studies. Donati et al. (2018) reported significant differences in marginal bone loss depending on implant position: implants in the anterior maxilla showed higher rates of loss than those in the posterior mandible. Cheng also reported higher survival rates for implants in the posterior mandible. Vrielinck et al. found a higher survival rate for fixed prostheses compared to removable appliances. Short implants and patients with bruxism showed a higher probability of complications. Roccuzzo, however, found no significant differences in survival rates between groups with different levels of periodontitis. These conflicting findings within the same review illustrate the complexity of biological complications: they are real, clinically significant, but their quantification depends heavily on case definition, follow-up duration, patient characteristics, and study design.

A summary of multiple studies on antiresorptive medications exemplifies how a risk factor can yield different results depending on the level of analysis. Fourteen non-randomized studies were included, and the risk of bias was assessed using the ROBINS-I tool. At the patient level (265 patients), there was no statistically significant difference in survival rates between patients with and without bisphosphonate therapy. However, at the implant level (2697 implants, 8 articles in the summary of multiple studies), the difference was statistically significant. The authors conclude that antiresorptive medications, particularly bisphosphonates, can significantly contribute to implant failure and impair osseointegration. At the same time, they report that failed implants in BP patients do not necessarily lead to osteonecrosis and can be successfully replaced. This demonstrates that even the choice of analysis unit (patient vs. implant) substantially influences the presentation of results and makes the assessment of a risk factor dependent on a methodological decision that is rarely communicated transparently.

Romandini et al. (2023) add the surgical dimension to the complication perspective. Their systematic review on flapless full-mouth implant placement (registered in PROSPERO, CRD42021283366) shows that while minimally invasive procedures reduce patient morbidity, they can simultaneously increase the risk of malpositioning if computer-guided navigation is not used. The study explicitly distinguishes between biologically correct and prosthetically correct positioning: Biologically correct positioning is defined as an implant surrounded by native bone at an ideal distance from adjacent teeth and implants, with the implant crown placed palatally or at the level of the gingival margin. Malpositions, which are more common in flapless surgery without guidance, are predictors of long-term biological complications including accelerated bone loss and soft tissue recession that may only manifest years after placement. The endpoint of success uncovers such causal chains, whereas the mere survival rate systematically obscures them.

Clinically, the complication perspective means that counseling an implant patient cannot end with just the probability of survival. A patient whose implant is still in place after 10 years but has already experienced two ceramic chips, a screw loosening, and 2 mm of periimplant bone loss lives in a fundamentally different clinical reality than a patient with a complication-free implant. Both are counted identically as success in survival statistics. The cumulative follow-up effort, the psychological burden from complications, and the financial follow-up costs are invisible in pure survival reporting.

For prosthetic planning, the complication analysis of the review yields concrete material decisions: Monolithic restorations made of zirconia or lithium disilicate tend to have lower fracture and chipping rates than veneered constructions. The relative failure rate for veneered vs. monolithic zirconia crowns is 1.69, and although the statistical confidence interval includes 1, the clinical trend is clear. Resin nano-composite crowns show unacceptably high failure rates with a relative failure rate of 25.8 compared to monolithic zirconia and must be critically evaluated for single implant-supported crowns. The choice between screw-retained vs. cemented constructions also influences the complication profile, as cement-retained restorations carry an additional risk of submucosal cement remnants.

In daily practice, this means that scientific evidence does not provide a one-size-fits-all answer but rather a framework for individualized decisions. Patient-specific factors such as general health, compliance, individual risk profiles, and treatment preferences must be incorporated into the decision.

What does "patient-centered success" mean for me as a patient?

One point that often causes uncertainty is patient-centered success. However, science has made important progress in recent years.

The most compelling empirical evidence regarding the influence of follow-up duration comes from a 20-year meta-analysis of several studies by Kupka et al. (2024), which systematically analyzed survival rates for dental implants over a 20-year period for the first time. The authors show a significant difference between 10- and 20-year survival rates: While the 10-year meta-analysis of several studies (Howe et al. with 2688 implants, Moraschini et al., Jung et al.) regularly reports survival rates above 90%, these rates drop to 78–92% in the 20-year window. The prospective complete case analysis yielded 92%, while imputing the dropouts lowered the rate to 78%. The retrospective studies showed 88%. These three figures from the same review demonstrate how strongly the methodological design influences the resulting survival rate—stronger than biological or material-specific factors. The total sample size of 1440 plus 237 implants is assessed by the authors as sufficient compared to previous meta-analyses that included between 101 and 1435 implants.

The dropout problem is particularly serious, and Kupka et al. (2024) discuss it in detail: In prospective long-term studies, patients are inevitably lost over 20 years, whether due to moving, death, changing practices, lack of interest in follow-up exams, or poor compliance. The complete case analysis only includes patients followed up until the end, thereby systematically overestimating the survival rate because patients with complications or implant losses are more likely to drop out of follow-up. The 14 percentage point difference between the complete case analysis (92%) and the imputed analysis (78%) is a quantitative measure of this potential bias. The authors explicitly emphasize that even the imputed data might be too optimistic, but the statistical range overlaps with that of the retrospective analyses, suggesting a realistic estimate. In the words of the authors: Presenting the individual figure of 4 out of 5 implants surviving after 20 years serves as a practical reference for patient understanding.

Hamilton et al. (2023) show an analogous phenomenon in short-term follow-up: With a mean follow-up of only 2.8 years and a mean number of implants of 37.2 per study, Type-I A studies (immediate placement with immediate loading) report expectedly high survival rates. Studies before 2012 with sometimes longer follow-up periods show significantly lower rates (−1.9 PP, P = 0.02). This can be attributed to both technological advancements (improved implant surfaces, more precise surgical protocols) and systematically shorter follow-up periods in newer studies. Both effects are inseparable in the aggregated literature, which makes it difficult to causally attribute the observed improvement. Additionally, all included studies used highly selective inclusion criteria, meaning that the reported rates represent a best-case selection, not routine care.

Scientific systematic reviews on the socket shield technique (Ogawa et al., 2022) illustrate a follow-up problem with a newer technique: Out of 274 evaluable cases involving 288 patients who received socket shields and immediate implant placement, complications or adverse effects occurred in 26 cases (9.5%). These included failed osseointegration, mobility and infection of the socket shield, exposure, migration, and apical root resorption. The 20 included studies comprised only one controlled study, two long-term observational studies, 14 clinical case reports, and three retrospective case series. The follow-up periods ranged from only 3 to 60 months. The quality assessment found that 12 of the 20 studies had good quality. The authors explicitly conclude that predicting the long-term success of this technique will only be possible when high-quality scientific evidence with longer follow-up periods and controlled study designs is available. This pattern is typical for implantology: New techniques are initially introduced with short-term survival data, which almost always look excellent, and it is only with increasing observation time that the true complication and failure patterns emerge.

Sailer et al. (2015), in their systematic review of metal-ceramic and all-ceramic tooth-supported single crowns, provide a methodological reference for the follow-up problem: A systematic search in MEDLINE, Embase, and Cochrane (2006–2013), supplemented by hand searching and 34 studies from previous reviews, yielded 5-year survival rates of 95.7% for metal-ceramic crowns and 93.5% for all-ceramic crowns, with complication profiles differing significantly depending on the material. Although this data pertains to tooth-supported and not implant-supported crowns, it forms an important point of comparison: Even with well-established restorative types, survival and complication rates vary systematically, and follow-up duration is a crucial moderator of reported results. The fact that even tooth-supported crowns with long evidence histories show considerable complication rates tempers expectations for implantological perfection.

Methodologically, it must be noted that the included studies vary significantly in study design, follow-up period, and patient selection. This heterogeneity limits the comparability of results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across different study types.

For transferability to the German-speaking care context, it is also relevant that a significant portion of the scientific evidence comes from Anglo-American or Scandinavian care systems. Differences in reimbursement structure, treatment culture, and patient access can influence effect sizes without invalidating the core message.

For daily clinical practice, the follow-up problem means that short-term survival rates are not a reliable basis for predicting the long-term prognosis of individual patients. The 20-year data from Kupka et al. (2024) suggest that a realistic expected value for 20-year implant retention is around 4 out of 5 implants, not 9 out of 10, as suggested by the 10-year literature. This difference has direct consequences for indication setting, especially in younger patients: The decision between tooth preservation and implantation should consider the patient's full time horizon, not just the 5-year data. Compared to orthopedic endoprostheses, implants still perform well: Total knee arthroplasty shows survival rates of 82%, and unicompartmental knee arthroplasty shows 70% after 25 years; total hip arthroplasty achieves only 60.4–77.7% after 20 years (Kupka et al. 2024).

The clinical implication is also a commitment to long-term aftercare. Kupka et al. (2024) explicitly state that follow-up cannot end after insertion or after 10 years. Many complications and implant losses only occur in the second decade, due to cumulative biological stress (periimplant inflammation, bone remodeling), material fatigue (screw loosening, fracture), changes in the patient's systemic health status (new medications, general illnesses), and biomechanical changes (loss of antagonists, occlusal overload). Ongoing monitoring identifies risk factors early and allows for preventive intervention.

In daily practice, this means that scientific evidence does not provide a one-size-fits-all answer but rather a framework for individualized decisions. Patient-specific factors such as general health, compliance, individual risk profiles, and treatment preferences must be factored into the decision.

What does this mean for you? Patient-centered perspectives prevent overly narrow success narratives.

What does this mean for your next dental appointment? The research findings help you better contextualize your dentist's recommendations and ask targeted questions if anything is unclear.

What makes these results reliable? In medical research, the rule is: the more independent studies that reach the same conclusion, the more certain the statement is. The type of study and the number of participants also play an important role. Large controlled studies with many participants provide more reliable results than small surveys.